Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium permanganate is an inorganic compound with the chemical formula KMnO4. It appears as a purplish-black crystalline salt that dissolves in water to give an intensely pink to purple solution[8]. Medically, it is used topically as an oxidizing agent for its disinfectant, deodorizing, and astringent properties[2][5]. Its primary indications include treatment of various skin conditions such as fungal infections (e.g., athlete's foot), impetigo, pemphigus, superficial wounds, dermatitis (eczema), and tropical ulcers[1][5]. The mechanism of action involves oxidation of organic material and microorganisms at the site of application. Potassium permanganate is not recommended for oral use due to toxicity risks. It is included on the World Health Organization's List of Essential Medicines[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium permanganate.